This study evaluates the effectiveness of universal newborn screening for Sickle Cell Disease (SCD) in the Murcia region between 2016 and 2023. SCD is a hereditary blood disorder caused by hemoglobin S, which distorts red blood cells and leads to vaso-occlusive crises, organ damage, severe infections, and increased childhood mortality. Early diagnosis is essential, as preventive measures -such as penicillin prophylaxis and parental education- significantly improve the prognosis.
The study covered more than 100,000 newborns screened via Capillary Electrophoresis using heel-prick blood samples. The majority of the 500 cases detected and confirmed by genetic testing involved carriers, specifically of Hb S or Hb C. The prevalence of Sickle Cell Anemia (Hb SS) and Hb SC disease was estimated at approximatively 1 per 10,000 births.
The program also offered genetic counseling, although language and socioeconomic barriers sometimes limited participation. The authors conclude that universal screening enables early treatment, specialized follow-up, and improved prevention, thereby justifying its continued implementation in regions experiencing increased migration flows.
Test associated with this resource
Related instrument
La automatización compacta y asequible de la electroforesis capilar.
La evolución marca la diferencia.
La experiencia de Sebia concentrada en un instrumento de alto rendimiento.
Discover more resources on Hemoglobin Disorders
Software completo de análisis e interpretación de datos para los ensayos de Sebia en instrumentos de electroforesis.
Esta sección contiene información destinada a una amplia difusión y, por lo tanto, puede incluir detalles de productos o información que no esté disponible o no sea válida en su país. Póngase en contacto con su representante local de Sebia. Información destinada a profesionales sanitarios. Lea atentamente las instrucciones que figuran en los prospectos de los reactivos y en los manuales de los instrumentos.